Evidence map›Paper›PMID 33084959›Full record

ReviewEuropean journal of nutrition2021

Micronutrients and bioactive compounds in the immunological pathways related to SARS-CoV-2 (adults and elderly).

Juliana Arruda de Souza Monnerat, Pedro Ribeiro de Souza, Letícia Monteiro da Fonseca Cardoso, João Dario Mattos, Gabrielle de Souza Rocha, Renata Frauches Medeiros

Abstract readReview
In one paragraph

Review in European journal of nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Tuberculosis in an Aging World.Pathogens (Basel, Switzerland) · 2022
    Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Juliana Arruda de Souza Monnerat *Cardiovascular Sciences Postgraduate Program-Federal Fluminense University, Niterói, RJ, Brazil. julianamonnerat@id.uff.br.ORCID http://orcid.org/0000-0002-5078-3731
Pedro Ribeiro de Souza *Cardiovascular Sciences Postgraduate Program-Federal Fluminense University, Niterói, RJ, Brazil.
Letícia Monteiro da Fonseca CardosoCardiovascular Sciences Postgraduate Program-Federal Fluminense University, Niterói, RJ, Brazil.
João Dario MattosBiomedical Sciences (Physiology) Postgraduate Program-Federal Fluminense University, Niterói, Rio de Janeiro, Brazil.
Gabrielle de Souza RochaCardiovascular Sciences Postgraduate Program-Federal Fluminense University, Niterói, RJ, Brazil.
Renata Frauches MedeirosCardiovascular Sciences Postgraduate Program-Federal Fluminense University, Niterói, RJ, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The new coronavirus pandemic is affecting the entire world with more than 25 million confirmed cases in August 2020 according to the World Health Organization. It is known that the virus can affect several tissues and can progress to a respiratory failure in severe cases. To prevent the progression to this stage of the disease and minimize all the damage caused by coronavirus (SARS-CoV-2) the immune system must be in its integrity. A healthy nutritional status are fundamental to efficient immunological protection and consequently a good response to SARS-CoV-2. Micronutrients and bioactive compounds perform functions in immune cells that are extremely essential to stop SARS-CoV-2. Their adequate consumption is part of a non-pharmacological intervention to keep the immune system functioning. This review has as main objective to inform how micronutrients and bioactive compounds could act in the essential immunological pathways could stop SARS-CoV-2, focusing on the functions that have already established in the literature and transposing to this scenario.

Indexed as

AdultAgedCOVID-19HumansImmune SystemMicronutrientsMiddle AgedPhytochemicalsSARS-CoV-2MicronutrientsPhytochemicalsBioactive compoundsCOVID-19ImmunityMicronutrientsSARS-CoV-2

Identifiers

PMID33084959
PMCPMC7576552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.